Cardiac troponin I serum concentrations in newborns: A study and review of the literature

被引:28
作者
Bader, D.
Kugelman, A.
Lanir, A.
Tamir, A.
Mula, E.
Riskin, A.
机构
[1] Technion Israel Inst Technol, Dept Neonatol, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, IL-31048 Haifa, Israel
[2] Technion Israel Inst Technol, Dept Biochem, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, IL-31048 Haifa, Israel
[3] Technion Israel Inst Technol, Lady Davis Carmel Hosp, Bruce Rappaport Fac Med, Dept Epidemiol & Publ Hlth, IL-31048 Haifa, Israel
关键词
cardiac troponin I (cTnI); serum concentrations; newborns;
D O I
10.1016/j.cca.2006.02.018
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Serum cardiac troponin I (cTnI) is a specific marker of cardiac injury. The use of cTnI in neonates, especially in relation to perinatal asphyxia has not been extensively examined. We defined the range of normal values of cTnI in newborns, and study factors that may influence these concentrations. Methods: Serum cTnI concentrations were measured on the third day of life in 179 normal newborns: 157 were term (after 37 weeks, mean: 39.7 +/- 1.1, range: 37-42) and 22 were premature infants (mean: 32.6 +/- 2.9, range: 27-36 weeks). Results: Mean cTnI for the term infants was 0.63 +/- 0.58 ng/ml (median: 0.50, range: 0.00-4.30). The concentration of 1.80 ng/ml, can serve as the upper limit of normal values. There was a borderline significant trend for higher cTnI in preterm infants. The number of newborns with cTnI > 1.80 ng/ml was significantly higher after delivery by caesarean section, compared to vaginal delivery (14.6% vs. 2.9%,p < 0.02). No other significant associations were found between cTnI and perinatal or neonatal parameters. Conclusions: Normal reference values for cTnI in healthy term newborns were defined, but need to be addressed with caution due to the wide range of normal values. 0 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 28 条
[11]   Cardiac troponin I in pediatrics: Normal values and potential use in the assessment of cardiac injury [J].
Hirsch, R ;
Landt, Y ;
Porter, S ;
Canter, CE ;
Jaffe, AS ;
Ladenson, JH ;
Grant, JW ;
Landt, M .
JOURNAL OF PEDIATRICS, 1997, 130 (06) :872-877
[12]  
Kanaan UB, 2004, PEDIATR EMERG CARE, V20, P323
[13]   NEW MONOCLONAL-ANTIBODIES AS PROBES FOR HUMAN CARDIAC TROPONIN .1. EPITOPIC ANALYSIS WITH SYNTHETIC PEPTIDES [J].
LARUE, C ;
DEFACQUELACQUEMENT, H ;
CALZOLARI, C ;
LENGUYEN, D ;
PAU, B .
MOLECULAR IMMUNOLOGY, 1992, 29 (02) :271-278
[14]  
LARUE C, 1993, CLIN CHEM, V39, P972
[15]   Fetal cardiac troponin I in relation to intrapartum events and umbilical artery pH [J].
McAuliffe, F ;
Mears, K ;
Fleming, S ;
Grimes, H ;
Morrison, JJ .
AMERICAN JOURNAL OF PERINATOLOGY, 2004, 21 (03) :147-152
[16]   Circulating cardiac troponin I in severe congestive heart failure [J].
Missov, E ;
Calzolari, C ;
Pau, B .
CIRCULATION, 1997, 96 (09) :2953-2958
[17]   DISTRIBUTION OF TROPONIN COMPONENTS IN THIN FILAMENT STUDIED BY IMMUNOELECTRON MICROSCOPY [J].
OHTSUKI, I .
JOURNAL OF BIOCHEMISTRY, 1975, 77 (03) :633-639
[18]   The effect of gestational age, birth weight, and disease on troponin I and creatine kinase MB in the first year of life [J].
Quivers, ES ;
Murthy, JN ;
Soldin, SJ .
CLINICAL BIOCHEMISTRY, 1999, 32 (06) :419-421
[19]   TROPONIN-I GENE-EXPRESSION DURING HUMAN CARDIAC DEVELOPMENT AND IN END-STAGE HEART-FAILURE [J].
SASSE, S ;
BRAND, NJ ;
KYPRIANOU, P ;
DHOOT, GK ;
WADE, R ;
ARAI, M ;
PERIASAMY, M ;
YACOUB, MH ;
BARTON, PJR .
CIRCULATION RESEARCH, 1993, 72 (05) :932-938
[20]   Pediatric reference ranges for creatine kinase, CKMB, troponin I, iron, and cortisol [J].
Soldin, SJ ;
Murthy, JN ;
Agarwalla, PK ;
Ojeifo, O ;
Chea, J .
CLINICAL BIOCHEMISTRY, 1999, 32 (01) :77-80